Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-13T16:09:07.772Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  29 January 2018

Phillip Cummins
Phillip Cummins*
Affiliation:
Assessment Unit, St Brendan's Hospital, PO Box 418, Ruthdown Road, Dublin 7
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 144 , Issue 5 , May 1984 , pp. 556
Copyright
Copyright © 1984 The Royal College of Psychiatrists 

References

Allan, R. N. & White, H. C. (1972) Side effects of parenteral longacting phenothiazines. British Medical Journal, 1, 221.Google Scholar
Caroff, S., Rosenberg, H. & Gerber, J. C. (1983) Neuroleptic malignant syndrome and malignant hyperthermia. Lancet, i, 244 Google Scholar
Delay, J. & Deniker, P. (1968) Drug induced extrapyramidal syndromes. In: Handbook of Clinical Neurology Vol. 6 Diseases of the Basal Ganglia, (eds. P. J. Vinkin & G. W. Bruyn). New York: Elsevier, North Holland, pp. 248–66.Google Scholar
Denborough, M. A. (1978) Current concepts of the etiology and treatment of malignant hyperthermia. In: Malignant Hyperthermia, (eds. J. A. Aldrete & B. A. Britt). New York: Grune & Stratton, pp. 537–44.Google Scholar
Henderson, V. W. & Wooten, G. F. (1981) Neuroleptic malignant syndrome: A pathogenic role for dopamine receptor blockade? Neurology (Ny), 31, 132–7.Google Scholar
Itoh, M., Ohtsuka, N., Ogita, K. et al (1977) Malignant neuroleptic syndrome—its present status in Japan and clinical problems. Folia Psychiatrica et Neurologica Japonica, 31, 565–76.Google Scholar
Meltzer, M. Y. (1973) Rigidity, hyperpyrexia and coma following fluphenazine enanthate. Psychopharmacologica, 29, 337–46.Google ScholarPubMed
Morris, H. H., McCormick, W. F. & Reinarz, J. A. (1980) Neuroleptic malignant syndrome. Archives of Neurology, 37, 462–3.CrossRefGoogle ScholarPubMed
Zubenko, G. & Pope, H. G. (1983) Management of a case of neuroleptic malignant syndrome with bjomocriptine. American Journal of Psychiatry, 140, 1619–20.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.